- Home
- BWXT vs PCVX Comparison
BWXT vs PCVX Comparison
Compare BWXT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWXT
- PCVX
- Stock Information
- Founded
- BWXT 1867
- PCVX 2013
- Country
- BWXT United States
- PCVX United States
- Employees
- BWXT N/A
- PCVX N/A
- Industry
- BWXT
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BWXT
- PCVX Health Care
- Exchange
- BWXT Nasdaq
- PCVX Nasdaq
- Market Cap
- BWXT 10.9B
- PCVX 14.7B
- IPO Year
- BWXT N/A
- PCVX 2020
- Fundamental
- Price
- BWXT $125.34
- PCVX $106.97
- Analyst Decision
- BWXT Buy
- PCVX Strong Buy
- Analyst Count
- BWXT 8
- PCVX 7
- Target Price
- BWXT $104.86
- PCVX $147.50
- AVG Volume (30 Days)
- BWXT 844.3K
- PCVX 636.4K
- Earning Date
- BWXT 11-04-2024
- PCVX 11-04-2024
- Dividend Yield
- BWXT 0.76%
- PCVX N/A
- EPS Growth
- BWXT 19.66
- PCVX N/A
- EPS
- BWXT 2.92
- PCVX N/A
- Revenue
- BWXT $2,600,935,000.00
- PCVX N/A
- Revenue This Year
- BWXT $8.08
- PCVX N/A
- Revenue Next Year
- BWXT $4.71
- PCVX N/A
- P/E Ratio
- BWXT $42.99
- PCVX N/A
- Revenue Growth
- BWXT 11.69
- PCVX N/A
- 52 Week Low
- BWXT $73.14
- PCVX $46.16
- 52 Week High
- BWXT $128.00
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BWXT 71.67
- PCVX 39.76
- Support Level
- BWXT $120.98
- PCVX $102.84
- Resistance Level
- BWXT $126.23
- PCVX $115.56
- Average True Range (ATR)
- BWXT 2.41
- PCVX 3.32
- MACD
- BWXT -0.37
- PCVX -1.41
- Stochastic Oscillator
- BWXT 79.24
- PCVX 21.55
About BWXT BWX Technologies Inc.
BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.